Skip to main content
An official website of the United States government
Español
Email

Screening & Early Detection - Cancer Currents Blog

News about research on cancer screening and early detection. Includes stories on the impact of screening, new technologies, and approaches to improving the safety and efficacy of screening.

  • Illustration of a set of scales with the word "benefits" outweighing the word "harms"
    • By Nadia Jaber

    In a review of 33 cancer screening guidelines, researchers have found that many don’t adequately capture the potential harms of cancer screening. Providing information on harms is critical so people can have informed discussions about screening with their health care providers, the researchers noted.

  • An African American woman undergoing a mammogram
    • By Linda Wang

    Many hospitals and community health centers are trying to increase cancer screening rates after the COVID pandemic caused them to plummet. The largest effort aims to add a total of 70,000 additional monthly screening tests over a 6-month period.

  • Factoid regarding the risk of colorectal cancer death being 2 times higher in those who did not get a follow-up colonoscopy
    • By Elia Ben-Ari

    People who had a positive FIT result (signs of blood in the stool) but didn’t get a follow-up colonoscopy were twice as likely to die of colorectal cancer as those who did get a colonoscopy, a new study found.

  • a cropped image of a physician's hand using a dermatoscope to look at a mole.
    • By Carmen Phillips

    Regular skin cancer screening leads to many diagnoses of very early-stage melanomas, results from a new study suggest. The results add to a debate about whether screening is fueling an overdiagnosis of melanoma in the United States.

  • Illustration depicting biomarkers in the bloodstream related to a tumor. The cross-section of a blood vessel shows various elements, including red blood cells, protein biomarkers, and circulating free DNA (cfDNA) biomarkers. An arrow points from a cluster of tumor cells into the blood vessel. Another arrow highlights cfDNA biomarkers with a label "Me," indicating methylation.
    • By Philip Castle, Ph.D., M.P.H.

    Progress has been made on developing noninvasive tests that may be able to find many cancers early. But, as NCI’s Dr. Phil Castle explains, there’s still much to learn about these multi-cancer early detection tests before they become widely used.

  • Image of cranial scan showing IDH1 mutant glioblastoma
    • By Nadia Jaber

    Researchers have been developing artificial intelligence (AI) tools that could make cancer imaging faster, more accurate, and more informative. But there are also questions about whether these tools are ready for doctors’ offices, whether they will actually help people, and whether that benefit will reach all—or only some—patients.

  • An infographic titled “Percentage of Women Overdue for Cervical Cancer Screenings.” A left box reads 14% in 2005, and an arrow points to a box on the right that reads 23% in 2019.
    • By Edward Winstead

    The rates of timely cervical cancer screening fell between 2005 and 2019, researchers found, and disparities existed among groups of women. The most common reason for not receiving timely screening was lack of knowledge about screening or not knowing they needed screening.

  • A doctor explaining results to her Black female patient
    • By Elia Ben-Ari

    Most breast cancer risk tools were developed with data mainly from White women and don’t work as well for Black women. A new tool that estimates risk for Black women may help identify those who might benefit from earlier screening, enabling earlier diagnosis and treatment.

  • A medical professional performs an ultrasound on a patient's neck to examine the thyroid gland.
    • By Sharon Reynolds

    Women are far more likely than men to be diagnosed with small thyroid cancers that probably would have never caused problems during their lifetime, a new study finds. The results may help explain why thyroid cancer seems to be more common in women.

  • Cancer Prevention Word Cloud
    • By Carmen Phillips

    The director of NCI’s Division of Cancer Prevention, Dr. Philip Castle, discusses the division’s priority areas and his vision for making more rapid progress in cancer prevention, including moving toward precision prevention and immunoprevention.

< Older Posts Newer Posts >
Email